patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: New PSTI stock offering...

Thanks Ron, it will be interesting to say the least. Also, thought this might be of interest as it is another mention of PSTI in a different format ( This was from an article dated 10-14-14 so I have to wonder if this is before or after your news about new stock??? ):

Dynavax carries a Zacks Rank #2 (Buy). Other well placed stocks in the health care sector include Plursistem, Inc. (PSTI - Snapshot Report) and Medivation Inc (MDVN - Analyst Report), each carrying a Zacks Rank #1 (Strong Buy).

Share
New Message
Please login to post a reply